2023-10-112024-12-312024-12-31false15203535UPSOLVE LABS UK LIMITED2025-07-1162012falseiso4217:GBPxbrli:pure152035352023-10-11152035352024-12-31152035352023-10-112024-12-31152035352023-10-10152035352023-10-10152035352023-10-102023-10-1015203535bus:SmallEntities2023-10-112024-12-3115203535bus:AuditExempt-NoAccountantsReport2023-10-112024-12-3115203535bus:FullAccounts2023-10-112024-12-3115203535bus:PrivateLimitedCompanyLtd2023-10-112024-12-3115203535core:WithinOneYear2024-12-3115203535core:AfterOneYear2024-12-3115203535core:WithinOneYear2023-10-1015203535core:AfterOneYear2023-10-1015203535core:ShareCapital2024-12-3115203535core:SharePremium2024-12-3115203535core:RevaluationReserve2024-12-3115203535core:OtherReservesSubtotal2024-12-3115203535core:RetainedEarningsAccumulatedLosses2024-12-3115203535core:ShareCapital2023-10-1015203535core:SharePremium2023-10-1015203535core:RevaluationReserve2023-10-1015203535core:OtherReservesSubtotal2023-10-1015203535core:RetainedEarningsAccumulatedLosses2023-10-1015203535core:LandBuildings2024-12-3115203535core:PlantMachinery2024-12-3115203535core:Vehicles2024-12-3115203535core:FurnitureFittings2024-12-3115203535core:OfficeEquipment2024-12-3115203535core:NetGoodwill2024-12-3115203535core:IntangibleAssetsOtherThanGoodwill2024-12-3115203535core:ListedExchangeTraded2024-12-3115203535core:UnlistedNon-exchangeTraded2024-12-3115203535core:LandBuildings2023-10-1015203535core:PlantMachinery2023-10-1015203535core:Vehicles2023-10-1015203535core:FurnitureFittings2023-10-1015203535core:OfficeEquipment2023-10-1015203535core:NetGoodwill2023-10-1015203535core:IntangibleAssetsOtherThanGoodwill2023-10-1015203535core:ListedExchangeTraded2023-10-1015203535core:UnlistedNon-exchangeTraded2023-10-1015203535core:LandBuildings2023-10-112024-12-3115203535core:PlantMachinery2023-10-112024-12-3115203535core:Vehicles2023-10-112024-12-3115203535core:FurnitureFittings2023-10-112024-12-3115203535core:OfficeEquipment2023-10-112024-12-3115203535core:NetGoodwill2023-10-112024-12-3115203535core:IntangibleAssetsOtherThanGoodwill2023-10-112024-12-3115203535core:ListedExchangeTraded2023-10-112024-12-3115203535core:UnlistedNon-exchangeTraded2023-10-112024-12-3115203535core:MoreThanFiveYears2023-10-112024-12-3115203535core:Non-currentFinancialInstruments2024-12-3115203535core:Non-currentFinancialInstruments2023-10-1015203535dpl:CostSales2023-10-112024-12-3115203535dpl:DistributionCosts2023-10-112024-12-3115203535core:LandBuildings2023-10-112024-12-3115203535core:PlantMachinery2023-10-112024-12-3115203535core:Vehicles2023-10-112024-12-3115203535core:FurnitureFittings2023-10-112024-12-3115203535core:OfficeEquipment2023-10-112024-12-3115203535dpl:AdministrativeExpenses2023-10-112024-12-3115203535core:NetGoodwill2023-10-112024-12-3115203535core:IntangibleAssetsOtherThanGoodwill2023-10-112024-12-3115203535dpl:GroupUndertakings2023-10-112024-12-3115203535dpl:ParticipatingInterests2023-10-112024-12-3115203535dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-112024-12-3115203535core:ListedExchangeTraded2023-10-112024-12-3115203535dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-112024-12-3115203535core:UnlistedNon-exchangeTraded2023-10-112024-12-3115203535dpl:CostSales2023-10-102023-10-1015203535dpl:DistributionCosts2023-10-102023-10-1015203535core:LandBuildings2023-10-102023-10-1015203535core:PlantMachinery2023-10-102023-10-1015203535core:Vehicles2023-10-102023-10-1015203535core:FurnitureFittings2023-10-102023-10-1015203535core:OfficeEquipment2023-10-102023-10-1015203535dpl:AdministrativeExpenses2023-10-102023-10-1015203535core:NetGoodwill2023-10-102023-10-1015203535core:IntangibleAssetsOtherThanGoodwill2023-10-102023-10-1015203535dpl:GroupUndertakings2023-10-102023-10-1015203535dpl:ParticipatingInterests2023-10-102023-10-1015203535dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-102023-10-1015203535core:ListedExchangeTraded2023-10-102023-10-1015203535dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-102023-10-1015203535core:UnlistedNon-exchangeTraded2023-10-102023-10-1015203535core:NetGoodwill2024-12-3115203535core:IntangibleAssetsOtherThanGoodwill2024-12-3115203535core:LandBuildings2024-12-3115203535core:PlantMachinery2024-12-3115203535core:Vehicles2024-12-3115203535core:FurnitureFittings2024-12-3115203535core:OfficeEquipment2024-12-3115203535core:AfterOneYear2024-12-3115203535core:WithinOneYear2024-12-3115203535core:ListedExchangeTraded2024-12-3115203535core:UnlistedNon-exchangeTraded2024-12-3115203535core:ShareCapital2024-12-3115203535core:SharePremium2024-12-3115203535core:RevaluationReserve2024-12-3115203535core:OtherReservesSubtotal2024-12-3115203535core:RetainedEarningsAccumulatedLosses2024-12-3115203535core:NetGoodwill2023-10-1015203535core:IntangibleAssetsOtherThanGoodwill2023-10-1015203535core:LandBuildings2023-10-1015203535core:PlantMachinery2023-10-1015203535core:Vehicles2023-10-1015203535core:FurnitureFittings2023-10-1015203535core:OfficeEquipment2023-10-1015203535core:AfterOneYear2023-10-1015203535core:WithinOneYear2023-10-1015203535core:ListedExchangeTraded2023-10-1015203535core:UnlistedNon-exchangeTraded2023-10-1015203535core:ShareCapital2023-10-1015203535core:SharePremium2023-10-1015203535core:RevaluationReserve2023-10-1015203535core:OtherReservesSubtotal2023-10-1015203535core:RetainedEarningsAccumulatedLosses2023-10-1015203535core:NetGoodwill2023-10-1015203535core:IntangibleAssetsOtherThanGoodwill2023-10-1015203535core:LandBuildings2023-10-1015203535core:PlantMachinery2023-10-1015203535core:Vehicles2023-10-1015203535core:FurnitureFittings2023-10-1015203535core:OfficeEquipment2023-10-1015203535core:AfterOneYear2023-10-1015203535core:WithinOneYear2023-10-1015203535core:ListedExchangeTraded2023-10-1015203535core:UnlistedNon-exchangeTraded2023-10-1015203535core:ShareCapital2023-10-1015203535core:SharePremium2023-10-1015203535core:RevaluationReserve2023-10-1015203535core:OtherReservesSubtotal2023-10-1015203535core:RetainedEarningsAccumulatedLosses2023-10-1015203535core:AfterOneYear2023-10-112024-12-3115203535core:WithinOneYear2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:CostValuation2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-112024-12-3115203535core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3115203535core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3115203535core:Non-currentFinancialInstrumentscore:CostValuation2023-10-1015203535core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-1015203535core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-1015203535bus:Director12023-10-112024-12-3115203535bus:Director22023-10-112024-12-31

UPSOLVE LABS UK LIMITED

Registered Number
15203535
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

UPSOLVE LABS UK LIMITED
Company Information
for the period from 11 October 2023 to 31 December 2024

Directors

BALANOVICH, Serguei
WU, Ka Ling

Company Secretary

TAYLOR WESSING SECRETARIES LIMITED

Registered Address

5 New Street Square
London
EC4A 3TW

Registered Number

15203535 (England and Wales)
UPSOLVE LABS UK LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

£

£

Fixed assets
Tangible assets37,151
7,151
Current assets
Debtors4208,013
Cash at bank and on hand68,586
276,599
Creditors amounts falling due within one year5(472,205)
Net current assets (liabilities)(195,606)
Total assets less current liabilities(188,455)
Net assets(188,455)
Capital and reserves
Called up share capital1,000
Profit and loss account(189,455)
Shareholders' funds(188,455)
The financial statements were approved and authorised for issue by the Board of Directors on 11 July 2025, and are signed on its behalf by:
WU, Ka Ling
Director
Registered Company No. 15203535
UPSOLVE LABS UK LIMITED
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The directors have assessed the company’s financial position and have a reasonable expectation that the company has adequate resources to operate for a period of twelve months from the date of approval of the financial statements. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Defined contribution pension plan
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the income statement in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

2024
Average number of employees during the year2
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions8,3048,304
At 31 December 248,3048,304
Depreciation and impairment
Charge for year1,1531,153
At 31 December 241,1531,153
Net book value
At 31 December 247,1517,151
At 10 October 23--
4.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables196,765
Other debtors11,069
Prepayments and accrued income179
Total208,013
5.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables3,072
Other creditors469,133
Total472,205
6.Operating lease commitments
At the balance sheet date, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £10,080.
7.Related party transactions
At the balance sheet date, the company owed loans to the following related parties. The loans are unsecured, interest-free, and repayable on demand. Upsolve Labs Inc. Parent Company £271,103.58 Ka Ling Wu Director £384.00